T. Galvez et al., Ca2+ requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: Involvement of serine 269 of the GABA(B)R1 subunit, MOLEC PHARM, 57(3), 2000, pp. 419-426
The gamma-aminobutyric acid (GABA) receptor type B (GABA(B)R) is constitute
d of at least two homologous proteins, GABA(B)R1 and GABA(B)R2. These prote
ins share sequence and structural similarity with metabotropic glutamate an
d Ca2+-sensing receptors, both of which are sensitive to Ca2+. Using rat br
ain membranes, we report here that the affinity of GABA and 3-aminopropylph
osphinic acid for the GABA(B)R receptor is decreased by a factor >10 in the
absence of Ca2+. Such a large effect of Ca2+ is not observed with baclofen
or the antagonists CGP64213 and CGP56999A. In contrast to baclofen, the po
tency of GABA in stimulating GTP gamma S binding in rat brain membranes is
also decreased by a factor >10 upon Ca2+ removal. The potency for Ca2+ in r
egulating GABA affinity was 37 mu M. In cells expressing GABA(B)R1, the pot
ency of GABA, but not of baclofen, in displacing bound I-125-CGP64213 was s
imilarly decreased in the absence of Ca2+. To identify residues that are re
sponsible for the Ca2+ effect, the pharmacological profile and the Ca2+ sen
sitivity of a series of GABA(B)R1 mutants were examined. The mutation of Se
r269 into Ala was found to decrease the affinity of GABA, but not of baclof
en, and the GABA affinity was found not to be affected upon Ca2+ removal. F
inally, the effect of Ca2+ on the GABA(B) receptor function is no longer ob
served in cells coexpressing this GABA(B)R1-S269A mutant and the wild-type
GABA(B)R2. Taken together, these results show that Ser269, which is conserv
ed in the GABA(B)R1 protein from Caenorhabditis elegans to mammals, is crit
ical for the Ca2+-effect on the heteromeric GABA(B) receptor.